The Transformative Impact of AI on Regulatory Affairs pharmafocusasia.com

Leveraging the capabilities of Natural Language Processing (NLP) in intelligent document analysis, Artificial Intelligence (AI) and machine learning technologies are transforming the landscape of regulatory affairs within the pharmaceutical sector. This transformation facilitates a more streamlined interaction between pharmaceutical companies and regulatory bodies, enhancing compliance processes. Furthermore, advancements in document management and machine learning are driving the regulatory framework towards heightened efficiency.